New Two-Pronged cancer drug enters human trials
NCT ID NCT04977453
Summary
This study is testing a new, experimental drug called GI-101 in people with advanced cancers that have spread. The main goals are to find a safe dose and see if the drug, given alone or with other approved cancer medicines, can help shrink tumors. The trial will enroll about 317 adults with specific advanced solid tumors, including certain lung, kidney, bladder, and cervical cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, 05505, South Korea
Contact
-
Carolina Biooncology Institute
RECRUITINGHuntersville, North Carolina, 28078, United States
Contact
-
Chungnam National University Hospital
RECRUITINGDaejeon, Daejeon, 65015, South Korea
Contact
-
Korea University Anam Hospital
RECRUITINGSeoul, Seongbuk-gu, 02841, South Korea
Contact
-
The Catholic University of Korea St. Vincent's Hospital
RECRUITINGSuwon, Kyeonggi-do, 16247, South Korea
Contact
-
Tisch Cancer Institute (TCI), Icahn School of Medicine
RECRUITINGNew York, New York, 10029-5674, United States
Contact
-
Yonsei University Health System, Severance Hospital
RECRUITINGSeoul, 03722, South Korea
-
Yonsei University Health System, Severance Hospital
RECRUITINGSeoul, 03722, South Korea
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.